XML 54 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2017
Segment Reporting Information [Line Items]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Information regarding the Company’s segments for the three and nine months ended September 30, 2017 and 2016 is as follows:
Revenues by segment
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
(in thousands)
 
2017
 
2016
 
2017
 
2016
Income generating assets
 
$
42,682

 
$
39,510

 
$
200,547

 
$
163,681

Pharmaceutical
 
15,104

 
14,128

 
43,897

 
14,128

Medical devices
 
4,963

 
—

 
7,580

 
—

Total revenues
 
$
62,749

 
$
53,638

 
$
252,024

 
$
177,809


Income (loss) by segment
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
(in thousands)
 
2017
 
2016
 
2017
 
2016
Income generating assets
 
$
25,248

 
$
14,049

 
$
98,746

 
$
74,084

Pharmaceutical
 
1,082

 
(142
)
 
(3,560
)
 
(142
)
Medical devices
 
(5,598
)
 
—

 
(6,774
)
 
—

Total net income
 
$
20,732

 
$
13,907

 
$
88,412

 
$
73,942


Long-lived assets by segment
 
 
 
 
(in thousands)
 
September 30,
2017
 
December 31,
2016
Income generating assets
 
$
145

 
$
38

Pharmaceutical
 
860

 
—

Medical devices
 
7,125

 
—

Total long-lived assets
 
$
8,130

 
$
38